A185750 Stock Overview
Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Chong Kun Dang Pharmaceutical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩97,000.00 |
| 52 Week High | ₩136,500.00 |
| 52 Week Low | ₩94,500.00 |
| Beta | 0.82 |
| 11 Month Change | -13.93% |
| 3 Month Change | -17.80% |
| 1 Year Change | -12.65% |
| 33 Year Change | -2.78% |
| 5 Year Change | 32.83% |
| Change since IPO | 89.57% |
Recent News & Updates
Is Chong Kun Dang Pharmaceutical (KRX:185750) Using Too Much Debt?
Oct 24
Investors Aren't Buying Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Earnings
Sep 27Does Chong Kun Dang Pharmaceutical (KRX:185750) Deserve A Spot On Your Watchlist?
Sep 08Are Investors Undervaluing Chong Kun Dang Pharmaceutical Corp. (KRX:185750) By 41%?
Jul 30Investors Don't See Light At End Of Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Tunnel
Jun 12Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly
May 27Recent updates
Is Chong Kun Dang Pharmaceutical (KRX:185750) Using Too Much Debt?
Oct 24Investors Aren't Buying Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Earnings
Sep 27Does Chong Kun Dang Pharmaceutical (KRX:185750) Deserve A Spot On Your Watchlist?
Sep 08Are Investors Undervaluing Chong Kun Dang Pharmaceutical Corp. (KRX:185750) By 41%?
Jul 30Investors Don't See Light At End Of Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Tunnel
Jun 12Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly
May 27A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
Apr 09Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?
Apr 19Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock
Apr 05Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?
Mar 09Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
Feb 24The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It
Feb 11Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?
Jan 27
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?
Jan 12With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting
Dec 28What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?
Dec 09Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?
Nov 24Shareholder Returns
| A185750 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -4.5% | -8.8% | -6.0% |
| 1Y | -12.7% | 9.9% | -4.4% |
Return vs Industry: A185750 underperformed the KR Pharmaceuticals industry which returned 9.9% over the past year.
Return vs Market: A185750 underperformed the KR Market which returned -4.4% over the past year.
Price Volatility
| A185750 volatility | |
|---|---|
| A185750 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A185750 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A185750's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 2,286 | Young-Joo Kim | www.ckdpharm.com |
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides. The company also exports its products.
Chong Kun Dang Pharmaceutical Corp. Fundamentals Summary
| A185750 fundamental statistics | |
|---|---|
| Market cap | ₩1.23t |
| Earnings (TTM) | ₩212.79b |
| Revenue (TTM) | ₩1.67t |
5.8x
P/E Ratio0.7x
P/S RatioIs A185750 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A185750 income statement (TTM) | |
|---|---|
| Revenue | ₩1.67t |
| Cost of Revenue | ₩1.01t |
| Gross Profit | ₩655.60b |
| Other Expenses | ₩442.81b |
| Earnings | ₩212.79b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.85k |
| Gross Margin | 39.34% |
| Net Profit Margin | 12.77% |
| Debt/Equity Ratio | 23.9% |
How did A185750 perform over the long term?
See historical performance and comparison